FDA Drug recall D-0232-2024
Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready…
- FDA Drug
- Class II
- ongoing
- Published 2024-01-24
On 2024-01-24 the FDA classified a Class II recall of Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready… by Par Sterile Products, citing superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0232-2024 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2024-01-11 |
| Published | 2024-01-24 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Par Sterile Products |
| Distribution | US |
Product
Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10
Reason
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Identifiers
| ndc | 42023-164-01 |
|---|---|
| ndc | 42023-164-25 |
| ndc | 42023-164-10 |
| ndc | 42023-190-01 |
| ndc | 42023-219-01 |
| ndc | 42023-219-10 |
| ndc | 42023-237-01 |
| ndc | 42023-237-10 |
| ndc | 42023-268-01 |
| ndc | 42023-268-10 |
| code_info | Lot # 66702; Exp. 02/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0232-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.